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Abstracts / Journal of Nutrition & Intermediary Metabolism 1 (2014) 1e5510Conclusions: The requirements of EPA and DHA in Atlantic salmon are
minimal; EPA is readily b-oxidised; EPA to DHA bioconversion is affected
by substrate availability, and not product presence; DHA is efﬁciently
conserved and deposited into the ﬁsh tissues.
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Background/Aims: Elevated levels of pro-inﬂammatory mediators heighten
the risk of developing/aggravating a spectrum of chronic diseases and are a
strong predictor of mortality in elderly cohorts. n-3PUFA (EPA and DHA) are
known to possess anti-inﬂammatory properties. This study was aimed to
determine ifn-3PUFAstatus is apredictorof inﬂammation inolderAustralians.
Methods: This study was a cross-sectional analysis of randomly selected
older men and women > 65 years (n ¼ 620) recruited from the Central
Coast of NSW, Australia. Fasting blood samples were analysed for C-reac-
tive protein (CRP), ﬁbrinogen and full blood count by an accredited pa-
thology service. The fatty acid composition of erythrocyte membranes was
analysed via GC to determine n-3PUFA (%EPA plus %DHA) status.
Results: After excluding participants who had an inﬂammatory disease or
CRP levels > 10 mg/L, or who were taking anti-inﬂammatory medications
or n-3PUFA supplements, 126 participants (male 42%; mean ± SD age 77.6
± 7 years) were included in the analysis. n-3PUFA status was inversely
associated with CRP (r ¼ -0.19, p < 0.05). However no association between
n-3PUFA status and ﬁbrinogen was detected (r ¼ -0.08, p ¼ 0.348).
Increased n-3PUFA levels were also associated with a reduced white blood
cell (r ¼ -0.20, p < 0.05), neutrophil (r ¼ -0.21, p < 0.05), monocyte (r ¼
-0.26, p < 0.01) and eosinophil (r ¼ -0.18, p ¼ 0.05) count.
Conclusions: The current study demonstrated a negative association be-
tween n-3PUFA status and markers of inﬂammation in an older popula-
tion. The ﬁndings support a potential role for n-3PUFA (EPA/DHA)
supplementation in the management of inﬂammatory conditions.
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Background/Aims: The inﬂuence of diets rich in saturated fatty acids (SFA)
or n-6PUFA in modulating blood lipid levels remains unclear. Recently we
hypothesised that the lipemic effects of saturated fats are dependent on n-
3PUFA status. This study aimed to examine the effects of consuming diets
rich in SFA or n-6PUFA when co-administered with marine n-3PUFA.
Methods: This was a randomised, controlled, parallel, dietary interven-
tion trial involving 16 healthy adults aged 18 to 65 years. Subjects
consumed a diet high in either SFA or n-6PUFA, each supplemented with
2.4 g n-3PUFA daily for 6 weeks. Blood samples were collected after an
overnight fast, at baseline and post-intervention, for analysis of blood
lipid proﬁle.
Results: A reduction in plasma triglyceride levels was noted post-inter-
vention, which was similar following consumption of the SFA+n-3PUFA or
the n-6PUFA+n-3PUFA diets (28% vs. 27% respectively). The SFA diet caused
a signiﬁcant rise in LDL (p ¼ 0.043) and HDL-cholesterol (p ¼ 0.05), while
the n-6PUFA had no effect on LDL or HDL-cholesterol levels. Total:HDL-
cholesterol or LDL:HDL-cholesterol ratios were not signiﬁcantly different
post-intervention for either of the diets. The change in total:HDL-choles-
terol or LDL:HDL-cholesterol ratios following SFA diet was also similar to
those on n-6PUFA diet.Conclusions: Dietary SFA and n-6PUFA differentially modulates plasma
lipid proﬁle when co-administered with n-3PUFA. The mechanism and
consequence of concomitant increase in HDL and LDL-cholesterol
following saturated fat consumption in association with n-3PUFA are
worthy of further examination.
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Background/Aims: In the Antenatal Shared Care (ANSC) model, pregnant
women are cared for by both their general practitioner (GP) and a public
antenatal clinic obstetrician. Clinical guidelines for ANSC recommend that
nutrition supplementation, including iodine, is discussed by GPs at the
women’s ﬁrst antenatal visit. The aim of this study was to assess knowledge
and practices related to iodine nutrition in both pregnant women and
healthcare providersparticipating in theANSCprogram in the Illawarra,NSW.
Methods: Pregnant women (n¼ 142) and GPs and practice nurses (n¼ 61)
completed knowledge and practice surveys about iodine. Pregnant women
additionally completed an iodine speciﬁc, validated food frequency
questionnaire.
Results: Both groups had poor knowledge about the importance and role
of iodine during pregnancy. Only 36% of women reported having received
adequate information about iodine, while 26% of GPs reported discussing
iodine supplementation with their pregnant patients. Most GPs (70%) did
not know the NHMRC recommended dosage of iodine for pregnancy
supplements (150 mg/day). Seventy percent of women reported taking
iodine supplements and 62% met the Estimated Average Requirement
(EAR) for iodine intake (160 mg/day). Most healthcare providers (74%)
expressed interest on receiving further education about iodine.
Conclusions: Both GPs and pregnant women in ANSC exhibited poor
knowledge about iodine. Despite this, women surveyed were meeting
their dietary requirements for iodine during pregnancy. Further education
of General Practice staff is indicated to ensure that all pregnant women are
encouraged to take a supplement containing iodine.
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Background/Aims: The aimof this studywas topilot test the effectonweight
loss of a novel interdisciplinary lifestyle intervention in the short term.
Methods: A 12week pilot randomised controlled parallel interventionwas
conducted in 22 adult volunteers (25-54 years; BMI 25-40 kg/m2) in
Wollongong, comparing usual care (general guidelines with practice
nurse) with a novel protocol integrating the efforts of exercise physiolo-
gists, dietitians, psychologist and medical practitioners. Detailed protocols
were developed, with ethics approval. Statistical analysis was conducted
using a linear mixedmodel (SPSS version 21, IBM corporation Armonk NY).
Results: After 3 months the intervention group lost signiﬁcantly more
weight than the control group, adjusted mean difference (AMD) -3.98 kg,
95%CI: -6.17, -1.79; and body fat, AMD -3.25%, 95%CI: -6.05, -0.48. This was
reﬂected in the changes in BMI, (AMD -1.24 kg/m2; 95%CI: -2.05, -0.44) and
waist circumference, (AMD -5.14 cm; 95%CI: -7.74, -2.53).
